Alger Health Sciences B
AHSBX
Price as of:
N/A
N/A
N/A
Primary Theme
N/A
fund company
N/A
Name
As ofPrice
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
N/A
1 yr return
-14.8%
3 Yr Avg Return
2.5%
5 Yr Avg Return
9.3%
Net Assets
$104 M
Holdings in Top 10
38.2%
52 WEEK LOW AND HIGH
N/A
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 2.09%
SALES FEES
Front Load N/A
Deferred Load 5.00%
TRADING FEES
Turnover 133.92%
Redemption Fee 2.00%
Min Investment
Standard (Taxable)
$1,000
IRA
$500
Fund Classification
Fund Type
Open End Mutual Fund
Name
As ofPrice
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
AHSBX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return 2.0%
- 5 Yr Annualized Total Return 9.1%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -1.83%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameAlger Health Sciences Fund
-
Fund Family NameAlger
-
Inception DateMay 01, 2002
-
Shares OutstandingN/A
-
Share ClassB
-
CurrencyUSD
-
Domiciled CountryUnited States
Fund Description
AHSBX - Performance
Return Ranking - Trailing
Period | AHSBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | 2.0% | 37.7% | N/A |
1 Yr | -14.8% | -25.0% | 10.1% | N/A |
3 Yr | 2.5%* | -17.4% | 21.9% | N/A |
5 Yr | 9.3%* | -11.0% | 18.6% | N/A |
10 Yr | 6.1%* | -1.9% | 15.7% | N/A |
* Annualized
Return Ranking - Calendar
Period | AHSBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -25.3% | 7.7% | N/A |
2022 | N/A | -10.8% | 43.9% | N/A |
2021 | N/A | -29.8% | 2.6% | N/A |
2020 | N/A | -20.4% | 13.8% | N/A |
2019 | N/A | -5.8% | 31.5% | N/A |
Total Return Ranking - Trailing
Period | AHSBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | 2.0% | 37.7% | N/A |
1 Yr | -18.3% | -25.0% | 13.9% | N/A |
3 Yr | 2.0%* | -17.4% | 25.0% | N/A |
5 Yr | 9.1%* | -11.0% | 20.7% | N/A |
10 Yr | 6.1%* | -1.9% | 18.9% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | AHSBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -25.3% | 12.3% | N/A |
2022 | N/A | -10.8% | 45.8% | N/A |
2021 | N/A | -24.2% | 8.7% | N/A |
2020 | N/A | -16.6% | 15.2% | N/A |
2019 | N/A | -5.8% | 36.7% | N/A |
AHSBX - Holdings
Concentration Analysis
AHSBX | Category Low | Category High | AHSBX % Rank | |
---|---|---|---|---|
Net Assets | 104 M | 13.8 M | 44.7 B | N/A |
Number of Holdings | 92 | 30 | 398 | N/A |
Net Assets in Top 10 | 45.9 M | 6.7 M | 18.8 B | N/A |
Weighting of Top 10 | 38.24% | 25.1% | 75.2% | N/A |
Top 10 Holdings
- Bristol-Myers Squibb Company 4.85%
- Biomarin Pharmaceutical Inc 4.34%
- Eli Lilly and Co 4.21%
- UnitedHealth Group Inc 4.18%
- Shire PLC ADR 3.99%
- Edwards Lifesciences Corp 3.79%
- Vertex Pharmaceuticals Inc 3.62%
- Biogen Inc 3.50%
- DexCom Inc 2.89%
- Abiomed Inc 2.85%
Asset Allocation
Weighting | Return Low | Return High | AHSBX % Rank | |
---|---|---|---|---|
Stocks | 96.91% | 91.85% | 103.82% | N/A |
Cash | 3.09% | 0.00% | 5.40% | N/A |
Preferred Stocks | 0.00% | 0.00% | 2.32% | N/A |
Other | 0.00% | -3.83% | 2.75% | N/A |
Convertible Bonds | 0.00% | 0.00% | 0.12% | N/A |
Bonds | 0.00% | 0.00% | 0.94% | N/A |
Stock Sector Breakdown
Weighting | Return Low | Return High | AHSBX % Rank | |
---|---|---|---|---|
Healthcare | 94.08% | 13.80% | 99.42% | N/A |
Technology | 0.46% | 0.00% | 61.10% | N/A |
Utilities | 0.00% | 0.00% | 0.00% | N/A |
Real Estate | 0.00% | 0.00% | 1.36% | N/A |
Industrials | 0.00% | 0.00% | 10.61% | N/A |
Financial Services | 0.00% | 0.00% | 5.80% | N/A |
Energy | 0.00% | 0.00% | 0.09% | N/A |
Communication Services | 0.00% | 0.00% | 0.00% | N/A |
Consumer Defense | 0.00% | 0.00% | 0.69% | N/A |
Consumer Cyclical | 0.00% | 0.00% | 7.87% | N/A |
Basic Materials | 0.00% | 0.00% | 1.91% | N/A |
Stock Geographic Breakdown
Weighting | Return Low | Return High | AHSBX % Rank | |
---|---|---|---|---|
US | 92.63% | 60.46% | 99.31% | N/A |
Non US | 4.28% | 0.00% | 39.02% | N/A |
AHSBX - Expenses
Operational Fees
AHSBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 2.09% | 0.10% | 2.98% | N/A |
Management Fee | 0.81% | 0.09% | 1.25% | N/A |
12b-1 Fee | 1.00% | 0.00% | 1.00% | N/A |
Administrative Fee | 0.03% | 0.01% | 0.40% | N/A |
Sales Fees
AHSBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 2.50% | 5.75% | N/A |
Deferred Load | 5.00% | 1.00% | 5.00% | N/A |
Trading Fees
AHSBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | 2.00% | 0.75% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
AHSBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 133.92% | 0.00% | 341.00% | N/A |
AHSBX - Distributions
Dividend Yield Analysis
AHSBX | Category Low | Category High | AHSBX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 0.01% | N/A |
Dividend Distribution Analysis
AHSBX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Annually | Annually |
Net Income Ratio Analysis
AHSBX | Category Low | Category High | AHSBX % Rank | |
---|---|---|---|---|
Net Income Ratio | -1.83% | -2.15% | 1.48% | N/A |
Capital Gain Distribution Analysis
AHSBX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |